Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Heart size and function uncoupled by researchers

20.09.2002


Proteins that work in immune system also play fundamental role in heart size and function



Researchers have identified two proteins that play fundamental roles in heart size and function and have genetically uncoupled them, a discovery the scientists hope will lead to better treatments for those with cardiovascular disease.

"We initially had a hint that the protein called PTEN controls cell size," says Josef Penninger, professor of medical biophysics and immunology at U of T, and lead author of a paper in the Sept. 20 issue of Cell. "We knew that cardiovascular disease triggers increased heart size and eventually heart failure so we set out to figure out if PTEN also has a function in the heart. We found that PTEN is absolutely critical to how large our hearts become. But to find out that it also plays a major part in controlling heart muscle pumping and function was completely novel and unexpected."


The PTEN and PI3K alpha and gamma proteins work in the body’s immune system. PTEN is also a major tumor suppressor for many cancers while PI3K gamma is known to control migration of white blood cells. Using genetically engineered mice, Penninger led an international team of researchers to examine what would happen if either of these proteins were removed from hearts.

Unchecked, PI3K alpha produces something that makes the heart bigger, Penninger explains. PTEN works as a negative regulator by shutting it down. When the researchers removed PTEN, the mice developed huge hearts; when production of the PI3K alpha protein was shut down, the hearts were only half-size. These two proteins work together to control heart size.

The researchers were further intrigued when they examined how the large and small hearts functioned. They found that the PI3K gamma protein, which governs how the heart muscle contracts and pumps, also works with PTEN in determining efficient heart function.

"The data is black and white," says Penninger. "When we knocked out PTEN, we had a huge heart and less function; when we knocked out PI3K gamma, we had normal heart size and much better function. With both of these proteins shut down, we had huge hearts and much better function. When we took out PI3K alpha, the mice had tiny hearts but normal function, and when we took out both PTEN and PI3K alpha, the mice had tiny hearts and heart failure. With these genes we can determine heart size and can genetically control how well our hearts pump, irrespective of the heart being normal or enlarged."

According to the World Health Organization, cardiovascular disease will be the most common cause of death within 20 years. This research goes directly to helping alleviate this disease, the researchers say. Every patient with heart or cardiovascular disease goes through a stage of heart enlargement. Those with hypertension, for example, need their heart to pump and contract more; as a result, the heart muscle enlarges to compensate for the extra work. At a certain point, however, this compensation doesn’t work anymore and the heart starts to fail.

The scientists hope that this research will form the basis for better treatments for people with chronic heart failure or cardiovascular disease. "The problem now is that there is no drug which maintains the pumping function of the heart," says Penninger. "We found the proteins that genetically control this. So the hope is that if you can shut down PI3K gamma, the heart will function much better after a heart attack or chronic heart failure, even if the patient has an enlarged heart."

The team of researchers who worked on this study are: Professor Peter Backx of physiology and medicine at U of T’s Heart & Stroke/Richard Lewar Centre; Michael Crackower, a post-doctoral fellow in Penninger’s lab; Gavin Oudit, a clinician scientist in Backx’s lab; Ivona Kozieradzki, Renu Sarao, Hai-Ying Cheng and Antonio Oliveira-dos-Santos of medical biophysics and immunology at U of T; Hui Sun of physiology and medicine at U of T’s Heart & Stroke/Richard Lewar Centre; and scientists from Japan, Italy, the United States and Switzerland.

Penninger was supported by a Canada Research Chair in Cell Biology, the National Cancer Institute of Canada and the Institute for Molecular Biotechnology of the Austrian Academy of Sciences. Crackower was supported in part by a Canadian Institutes of Health Research fellowship. The study was also supported by AMGEN Inc., the American Heart Association and the National Institutes of Health.

CONTACT:

U of T Public Affairs, ph: (416) 978-5949; email: jf.wong@utoronto.ca

Janet Wong | EurekAlert!
Further information:
http://www.newsandevents.utoronto.ca/bin3/020919a.asp

More articles from Health and Medicine:

nachricht How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Let the good tubes roll

19.01.2018 | Materials Sciences

How cancer metastasis happens: Researchers reveal a key mechanism

19.01.2018 | Health and Medicine

Meteoritic stardust unlocks timing of supernova dust formation

19.01.2018 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>